Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wihlborgs Fastigheter AB (publ) AGM 2018

Bulletin from Wihlborgs Fastigheter AB's Annual General Meeting 25 April.At Wihlborgs Fastigheter AB’s AGM on 25 April 2018, the meeting agreed to the Board’s proposal for a dividend for 2017 of SEK 6.25 per share. The record date for receiving the dividend was set at Friday, 27 April 2018. Cash payment will be sent by Euroclear Sweden AB on Thursday 3 May 2018. The Board of Directors and the CEO were granted freedom of responsibility for the year 2017. The AGM approved the Board’s proposal for principles governing remuneration and other terms of employment for corporate management.

Report from Annual General Meeting

At the Annual General Meeting of SaltX Technology Holding AB (publ) on April 25, it was decided in accordance with proposals of the nomination committee and the Board.The AGM took the following decisions. All decisions were in accordance with the proposals submitted and are described in detail in the AGM materiel available on the company's website. · Determination of income statement, balance sheet and consolidated income statement and consolidated balance sheet for 2017 · Profit allocation in accordance with the Board's proposal, which means that no profit distribution is given for

Communiqué from GHP’s Annual General Meeting 2018

The Annual General Meeting of GHP Specialty Care AB (publ) held on 25 April 2018 adopted the following resolutions:· In order to prioritise investments for stronger growth in the current year, it was decided that no dividend will be paid for the financial year 2017. · Decisions were made for discharge to the Board and the CEO for the 2017 fiscal year. · Re-election of the members of the Board Carsten Browall, Bo Wahlström, Mikael Olsson,Johan Wachtmeister and Elisabeth Hansson until the end of the next Annual General Meeting. Carsten Browall was elected as Chairman of the Board.

Annual General Meeting of NetEnt AB (publ) on April 25, 2018

At NetEnt AB (publ)’s annual general meeting on Wednesday April 25, 2018, the following was resolved. Adoption of financial statements and dividendThe annual general meeting (AGM) adopted the income statement and balance sheet along with the consolidated income statement and balance sheet and resolved that no dividend is to be paid for the financial year 2017. Please note the section regarding share split and automatic redemption procedures below. Board of DirectorsThe Board of Directors and the President and CEO were discharged from liability for the financial year 2017. The AGM

Bulletin from the Annual General Meeting of Formpipe Software AB held 25 April 2018

Allocation of retained earnings and discharge from liabilityThe Annual General Meeting (AGM) approved the Board of Directors’ proposal that SEK 0.50 per share shall be paid in dividend to the shareholders for the financial year 2017, and that the record date for the dividend shall be 27 April 2018. The dividend is expected to be distributed by Euroclear Sweden AB on 3 May 2018. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2017. Election of directors, chairman of the Board, auditor, fees, and principles for appointment of the

Invitation to presentation of Immunovia´s interim report January-March 2018 on April 27, 2018

Lund (Sweden) - Immunovia will publish the company’s interim report for the period January-March 2018 on Friday, April 27, at 08:00 a.m. CET.Immunovia invites to a teleconference (in English) for investors, analysts and media on April 27, at 3:30 – 4:30 p.m. CET. Mats Grahn, CEO will present Immunovia and comment on the interim report followed by a Q&A-session. Please call in a few minutes in advance. To attend, please dial-in at one of the numbers below from: Telephone: SE: +46856642662BE: +3224040635CH: +41225675548DE: +4969222229046DK: +4582333178FR: +33170750725NE:

DECISION REGARDING SHARE BUYBACK.

The Board of Semcon AB (publ) has, pursuant to the authorization of the Annual General Meeting of 25 April 2018, resolved to buyback up to 200,000 ordinary shares.The Board of Semcon AB (publ) has, pursuant to the authorization of the Annual General Meeting of 25 April 2018, resolved to buyback up to 200,000 ordinary shares. The Board’s decision aims to improve the company’s capital structure. Acquisitions may be made on one or more occasions during the period between 2 May 2018 and the 2019 Annual General Meeting. A total of no more than 200,000 ordinary shares may be acquired.

Stena Line and Mercy Ships forerunners in fundraising

Stena Line and Mercy Ships were awarded “Company collaboration of the year” at the charity event Insamlingsforum 2018 in Stockholm on 24 April. The motivation highlights both the recent fundraising coffee campaign onboard and the Stena Line volunteer program and call the partnership a forerunner within company collaborations."The partnership with Mercy Ships enables us to make a difference and take a greater social responsibility in a way we have never been able to do before. I proudly share this award with Mercy Ships and all Stena Line employees and customers that contributed during the

Promore Pharma 2017 Annual report published

STOCKHOLM, 25 april, 2018 – The 2017 Annual report of Promore Pharma AB (publ) is now available on the company website, promorepharma.com.Printed copies can be ordered from Promore Pharma AB, Karolinska Institutet Science Park, Fogdevreten 2, SE-171 65 Solna, or by e-mail info@promorepharma.com. For additional information, please contact Jonas Ekblom, VD Tel: [+46] 736 777 540 E-mail: jonas.ekblom@promorepharma.com Jenni Björnulfson, CFO Tel: [+46] 708 55 38 05 E-mail: jenni.bjornulfson@promorepharma.com This information is information that Promore Pharma AB is

Resolutions at Eniro’s Annual General Meeting 2018 and the Board’s resolution on remaining part of the commitment fee issue

Eniro AB (publ) (“Eniro” or “the Company”) today held its Annual General Meeting (AGM), which among other items of business elected Board of Directors, adopted the 2017 annual accounts, granted the Board of Directors discharge from liability, and resolved on a reverse share split of ordinary shares and amendments of the Articles of Association. The most important resolutions passed by the AGM are summarized below. The Board of Directors has also decided to implement the remaining part of the commitment fee issue. The AGM voted in favor of the following resolutions, among others: 1.

Annual general meeting in Bonava AB (publ) on 25 April 2018

Bonava's annual general meeting (“AGM”) was held on Wednesday, 25 April 2018, at 3 pm, in Stockholm, Sweden.Adoption of the income statement and balance sheet and the consolidated income statement and consolidated balance sheet The AGM adopted the income statement and balance sheet of the parent company and the group for the preceding year. Dividend The AGM approved the proposed shareholder dividend of SEK 5.20 per share. It was decided that the dividend should be distributed in two installments. At the first installment, SEK 2.60 per share shall be distributed and at the second

Bong Annual Report 2017

Bong AB’s Annual Report is now available at Bong’s website bong.com. The printed version is being distributed to the shareholders and can also be ordered from the Bong head office or via the company’s website. As previously communicated, Bong’s Annual General Meeting will be held on 16 May 2018 at 4.00 p.m. CET at Malmö Börshus, Skeppsbron 2 in Malmö. Notification of attendance must be made on 9 May at the latest. This is information that Bong AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 16.45 CET on 25 April

RESOLUTIONS AT SEMCON’S ANNUAL GENERAL MEETING 2017.

Semcon’s Annual General Meeting (AGM) was held on Wednesday April 25, 2018 at the company’s head office on Lindholmsallén 2 in Göteborg, Sweden. The AGM took inter alia the following resolutions.AdoptionThe AGM adopted the parent company and consolidated income statements and balance sheets.DividendThe AGM resolved in accordance with the Board’s proposal to give a dividend of SEK 3.50 per share. In total the dividend amounts to SEK 61.9 million. The remaining disposable profit, around SEK 247 million, will be brought forward. The record date for the dividend is April 27, 2018 and

Citycon Oyj: Managers’ Transactions

CITYCON OYJ   Managers’ Transactions   25 April 2018 at 17:25 hrsPerson subject to the notification requirement: Marcel Kokkeel, CEOIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification type: initial notificationReference number: 549300P8N0P6KDGTJ206_20180425151128_2TransactionDate: 25 April 2018Venue: Nasdaq Helsinki Ltd (XHEL)Nature of the transaction: acquisitionInstrumentshare (CTY1S)ISIN Code: FI0009002471Transaction details(1): volume: 1,825, unit price: 1.84600 EUR(2): volume: 1,383, unit price: 1.84600 EUR(3): volume: 617, unit price: 1.84600 EUR(4):

Restamax Plc: DECISIONS OF RESTAMAX PLC'S ANNUAL GENERAL MEETING

Restamax PlcSTOCK EXCHANGE RELEASE 25 APRIL 2018 at 17:15DECISIONS OF RESTAMAX PLC'S ANNUAL GENERAL MEETINGRestamax Plc's Annual General Meeting was held today 25 April 2018 in Tampere The meeting confirmed the 2017 financial statements and discharged the company's management from liability. The meeting decided that, based on the balance sheet confirmed for the financial period that ended on 31 April 2017, a dividend of EUR 0.33 per share will be paid. The dividend will be paid on 9 May 2018. The Annual General Meeting decided that the Board of Directors will comprise six (5) members

SyntheticMR initiates the listing process for NASDAQ OMX

The Board of SyntheticMR has decided to start the process regarding change of trading venue for the company's shares from Aktietorget to NASDAQ OMX Stockholm. The company's ambition is to complete the change of list in the latter part of 2019.A listing on NASDAQ OMX is assessed by the Board to strengthen the quality mark for SyntheticMR and to create greater interest in the company's share. In addition, listing should increase trust from global customers and stakeholders. "Since SyntheticMR was listed on Aktietorget, much has been achieved in the company. We have signed several

Citycon Oyj: Managers’ Transactions

CITYCON OYJ   Managers’ Transactions   25 April 2018 at 17:00 hrsPerson subject to the notification requirement: Gazit Globe Ltd., Closely associated person(X) Legal personPerson discharging managerial responsibilities in issuer: Chaim Katzman, Chairman of the Board of DirectorsIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification type: initial notificationReference number: 549300P8N0P6KDGTJ206_20180425093257_3TransactionDate: 23 April 2018Venue: Off-Exchange Transactions (XOFF)Nature of the transaction: acquisitionInstrumentshare (CTY1S)ISIN Code: FI0009002471

Resolutions at Thule Group’s Annual General Meeting 2018

At the Annual General Meeting of Thule Group AB held on 25 April 2018, the following was resolved.Election of Board of DirectorsBengt Baron, Hans Eckerström, Eva Elmstedt, Liv Forhaug and Heléne Mellquist were re‑elected as members of the Board. Mattias Ankarberg was elected as new member of the Board. Bengt Baron was elected as Chairman of the Board. Fees to the Board of DirectorsIt was resolved that Board fees shall be paid by SEK 925,000 to the Chairman of the Board and SEK 360,000 to each of the Board members elected by the AGM. Work in the Audit Committee shall be remunerated

Castellum revises its financial policy – Loan-to-value ratio reduced to max. 50%

Castellum’s ambition is to further strengthen its profile as a commercial real estate company featuring low financial risk. The Board has therefore decided to change current financial policies and decrease the net loan-to-value ratio: not to exceed 50% on a sustained basis – from the current level of 55%.Furthermore, current restrictions limiting the share of capital-market financing to a maximum 75% of outstanding interest-bearing liabilities will be discontinued. In addition, the Board will introduce a new restriction concerning secured financing. Here, the objective is to limit the ratio

Peab extends hospital in Norway

Peab has been commissioned to extend Martina Hansens Hospital in Baerum, south of Oslo. The customer is the Martina Hansens Hospital Institute and the contract is worth NOK 192 million.The project encompasses a new seven story building with a total building area of 5,000 m2. This is a turnkey contract and work on it will begin in May 2018. The project is expected to be completed in August 2020.   The project will be order registered in the second quarter of 2018. For further information, please contact: John Ivar Mejlænder-Larsen, Region Manager Peab cell: +47 913 10 470 Kajsa

Trading halt in Norinvent AB’s share

AktieTorget has today April 25th, 2018, decided to halt the trading in the shares of Norinvent AB (NORI).The reason for the trading halt is that AktieTorget finds the Company´s situation is such that conditions may harm the interests of the investors. More information is expected from the Company. AktieTorget+ 46 8-511 68 000Email informationsovervakare@aktietorget.se  About AktieTorget AktieTorget is a market place that wants to make it easier, safer and more visible for growth companies to become- and be listed. The company also offers investors the opportunity to become

Veidekke ASA: New revenue recognition standard takes effect - IFRS 15

The IFRS 15 revenue recognition standard took effect on 1 January 2018. The new standard is relevant to Veidekke's recognition of revenue from residential projects as well as change orders and supplementary work in construction projects. The 2017 annual accounts have been restated in accordance with the new standard. Residential projects in property development operationsIn the financial statement, Veidekke has, in accordance with the previous standard IAS 11, recognised revenue from residential projects on the date of contractual delivery to the purchaser (IFRIC 15). In accordance

LeoVegas comments on information regarding the potential for changing circumstances in the Norwegian market

In LeoVegas financial targets of at least EUR 600 million in revenue in 2020 and at least EUR 100 million in EBITDA in 2020, that were presented on April 19th, it has been taken into account that market conditions can change. The announcement yesterday about the proposal in the Norwegian Parliament is an example of changing conditions that LeoVegas' strategic planning has made room for. LeoVegas strives to be a transparent company and therefore chooses to disclose the size of the Norwegian market in order to increase understanding of the potential impact. In March 2018, the Norwegian

TORM plc Long-Term Incentive Program

In accordance with TORM plc's ("TORM") Remuneration Policy adopted by the Annual General Meeting  of TORM plc on 12 April 2018, the Board of Directors has as part of a new long-term incentive program decided to grant certain employees (the "Participants") Restricted Share Units ("RSUs") in the form of restricted stock options. The RSUs aim at incentivizing the Participants to seek to improve the performance of TORM and thereby the TORM share price for the mutual benefit of themselves and the shareholders of TORM.The Board of Directors of TORM expects to grant the Participants a total of

There are no items matching the current filter
There are no more items matching the current filter
Back to top